abstract |
A PROCEDURE IS DESCRIBED FOR INHIBITING THE INHIBITOR 1 OF THE PLASMINOGEN ACTIVATOR, WHICH INCLUDES MANAGING A HUMAN WHO NEEDS AN EFFECTIVE AMOUNT OF A COMPOUND PRESENTING FORMULA (I), IN WHICH R 1 AND R 3 ARE INDENDENTLY HYDRO - CH 3, (A) OR (B), BEING THE OPTIONALLY REPLACED PHENYL; R 2 IS SELECTED BETWEEN THE GROUP FORMED BY PIRROLIDINA, HEXAMETILENIMINO AND PIPERIDINO; OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATO OF THE SAME. |